Counsel
CurrentI followed my former Troutman Pepper team to Goodwin Procter, where I will continue to support private equity and strategic M&A transactions in the healthcare sector by: (i) overseeing the healthcare regulatory issues raised by such transactions, including regulatory risk evaluations (buy-side and sell-side); (ii) addressing compliance and reimbursement issues; and (iii) determining licenses, permits and registrations required as a result of such transactions. My specific areas of regulatory expertise include: (i) federal fraud and abuse laws (Anti-Kickback Statute, Stark (self-referral prohibitions), false claims, civil monetary penalties, etc., and corresponding state laws; (ii) HIPAA privacy and security; (iii) Medicare Part D (pharmacy benefit plans); pharmacy licensing; (iv) pharmacy and facility licensing; (v) effects of transactions (changes in ownership) on healthcare licensure and registration/notice requirements; and (vi) corporate practice of medicine and fee splitting.